Atrial natriuretic peptide clearance receptor participates in modulating endothelial permeability

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 275, Issue 5 44-5, 1998, Pages

  Hempel, Albrecht ^a   Noll, Thomas ^b   Bach, Christoph ^a   Piper, Hans Michael ^d   Willenbrock, Roland ^a   Höhnel, Klaus ^a   Haller, Hermann ^a   Luft, Friedrich C ^a,c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c FRANZ VOLHARD CLINIC   (Germany)

^d NONE

Author keywords

Atrial natriuretic peptide receptors; cAMP; cGMP; Endothelial permeability

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR RECEPTOR; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE;

ANIMAL CELL; ARTERY ENDOTHELIUM; ARTICLE; CELL MEMBRANE PERMEABILITY; CORONARY ARTERY; ENDOTHELIUM CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; TRANSPORT KINETICS;

EID: 0031724890     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1998.275.5.h1818     Document Type: Article

References (48)

1. Almeida, F. A., M. Suzuki, R. M. Scarborough, J. A. Lewicki, and T. Maack. Clearance function of C receptors of atrial natriuretic factor in rats. Am. J. Physiol. 256 (Regulatory Integrative Comp. Physiol. 25): R469-R475, 1989.
2. Anand-Srivastava, M. B., J. Gutkowska, and M. Cantin. The presence of atrial natriuretic factor receptors of ANF-R2 subtype in rat platelets. Coupling to adenylate cyclase/cyclic AMP signal-transduction. Biochem. J. 278: 211-217, 1991.
3. Anand-Srivastava, M. B., M. R. Sairam, and M. Cantin. Ring-deleted analogs of natriuretic factor inhibit adenylate cyclase/cAMP-system. J. Biol. Chem. 265: 8566-8572, 1990.
4. Arad, M., N. Zamir, L. Horowitz, T. Oxman, and B. Rabinowitz. Release of atrial natriuretic peptide in brief ischemia-reperfusion in isolated rat hearts. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H1971-H1978, 1994.
5. Baron, D. A., C. E. Lofton, W. H. Newman, and M. G. Currie. Atriopeptin inhibition of thrombin-mediated changes in the morphology and permeability of endothelial monolayers. Proc. Natl. Acad. Sci. USA 86: 3394-3398, 1989.
6. Battle, T., J. B. Michel, and B. Corman. Effect of atrial natriuretic factor on the water permeability of endothelial cells. Biochem. Biophys. Res. Commun. 185: 386-391, 1992.
7. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
8. Brenner, B. M., B. J. Ballermann, M. E. Gunning, and M. L. Zeidel. Diverse biological actions of atrial natriuretic peptide. Physiol. Rev. 70: 665-699, 1990.
9. Burnett, J. C. Coronary endothelial function in health and disease. Drugs 3, Suppl. 1: 20-29, 1997.
10. Cahill, P., and A. Hassida. Clearance receptor-binding atrial natriuretic peptides inhibit mitogenesis and proliferation of rat aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 179: 1606-1613, 1991.
11. Chang, M.-S., D. G. Lowe, M. Lewis, R. Hellmiss, E. Chen, and D. V. Goeddel. Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature 338: 78-83, 1989.
12. Chinkers, M., D. L. Garbers, M.-S. Chang, D. G. Lowe, H. Chin, D. V. Goedel, and S. Schulz. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 338: 78-83, 1989.
13. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
14. Diwan, A. H., W. J. Thompson, A. K. Lee, and S. J. Strada. Cyclic GMP-dependent protein kinase activity in rat pulmonary microvascular endothelial cells. Biochem. Biophys. Res. Commun. 202: 728-735, 1994.
15. Drewett, J. G., R. J. Ziegler, and G. J. Trachte. Neuromodulatory effects of atrial natriuretic peptides correlate with an inhibition of adenylate cyclase but not an activation of guanylate cyclase. J. Pharmacol. Exp. Ther. 260: 689-696, 1991.
16. Flückiger, J. P., B. Waeber, G. Matsueda, B. Delaloye, J. Nussberger, and H. R. Brunner. Effect of atriopeptin III on hematocrit and volemia of nephrectomized rats. Am. J. Physiol. 251 (Heart Circ. Physiol. 20): H880-H883, 1986.
17. Heim, J. M., S. Kiefersauer, H. J. Fulle, and R. Gerzer. Urodilatin and beta-ANF: binding properties and activation of particulate guanylate cyclase. Biochem. Biophys. Res. Commun. 163: 37-41, 1989.
18. Hempel, A., M. Friedrich, K. D. Schlüter, W. G. Forssmann, M. Kuhn, and H. M. Piper. ANP protects against reoxygenation-induced hypercontracture in adult cardiomyocytes. Am. J. Physiol. 273 (Heart Circ. Physiol. 42): H244-H249, 1997.
19. Hempel, A., T. Noll, A. Muhs, and H. M. Piper. Functional antagonism between cAMP and cGMP on permeability of coronary endothelial monolayers. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H1234-H1271, 1996.
20. Hirata, M., C.-H. Chang, and F. Murad. Stimulatory effects of atrial natriuretic factor on phosphoinositide hydrolysis in cultured bovine aortic smooth muscle cells. Biochim. Biophys. Acta. 1010: 346-351, 1989.
21. Hu, R. M., E. R. Levin, A. Pedram, and H. J. L. Frank. Atrial natriuretic peptide inhibits the production and secretion of endothelin from cultured endothelial cells. J. Biol. Chem. 267: 17384-17389, 1992.
22. Hutchinson, H. G., P. T. Trindade, D. B. Cunanan, C.-F. Wu, and R. E. Pratt. Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells. Cardiovasc. Res. 35: 158-167, 1997.
23. 2 in rabbit isolated vasa deferentia. J. Pharmacol. Exp. Ther. 257: 720-726, 1991.
24. 2-adrenergic stimulation in vascular smooth muscle cells. J. Biol. Chem. 269: 28300-28308, 1994.
25. Kubes, P., and D. N. Granger. Nitric oxide modulates microvascular permeability. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H611-H615, 1992.
26. Lang, R. E., H. Thoelken, D. Ganten, F. C. Luft, H. Ruskoaho, and T. Unger. Atrial natriuretic factor: a circulating hormone stimulated by volume loading. Nature 314: 264-266, 1985.
27. Lofton, C. E., D. A. Baron, J. E. Heffner, M. G. Currie, and W. H. Newman. Atrial natriuretic peptide inhibits oxidant-induced increases in endothelial permeability. J. Mol. Cell. Cardiol. 23: 919-927, 1991.
28. Lum, H., and A. B. Malik. Regulation of vascular endothelial barrier function. Am. J. Physiol. 267 (Lung Cell. Mol. Physiol. 11): L223-L241, 1994.
29. Maack, T., M. Suzuki, F. A. Almeida, D. Nussenzveig, R. M. Scarborough, G. A. McEnroe, and J. A. Lewicki. Physiological role of silent receptors of atrial natriuretic factor. Science 238: 675-678, 1987.
30. MacMillan-Crow, L. A., J. E. Murphy-Ullrich, and T. M. Lincoln. Identification and possible localization of cGMP-dependent protein kinase in bovine aortic endothelial cells. Biochem. Biophys. Res. Commun. 201: 531-537, 1994.
31. Needleman, P., E. H. Blaine, J. E. Greenwald, M. L. Michener, C. B. Saper, P. T. Stockmann, and H. E. Tolunay. The biochemical pharmacology of atrial peptides. Annu. Rev. Pharmacol. Toxicol. 29: 23-54, 1989.
32. Noll, T., A. Hempel, and H. M. Piper. Neuropeptide Y reduces macromolecule permeability of coronary endothelial monolayers. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H1878-H1883, 1996.
33. Noll, T., A. Muhs, M. Besselmann, H. Watanabe, and H. M. Piper. Initiation of hyperpermeability in energy-depleted coronary endothelial monolayers. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H1462-H1470, 1995.
34. Pedram, A., R. Mahnaz, R.-M. Hu, and E. R. Levin. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J. Biol. Chem. 272: 17097-17103, 1997.
35. Piper, H. M., R. Spahr, S. Mertens, A. Krützfeldt, and H. Watanabe. Microvascular endothelial cells from heart. In: Cell Culture Techniques in Heart and Vessel Research, edited by H. M. Piper. Heidelberg, Germany: Springer, 1990, p. 158-177.
36. Schaeffer, R. C., F. Gong, and M. S. Bitrick. Restricted diffusion of macromolecules by endothelial monolayers and small-pore filters. Am. J. Physiol. 263 (Lung Cell. Mol. Physiol. 7): L27-L36, 1992.
37. Schulz, M.-S., S. Singh, R. A. Bellet, G. Singh, D. J. Tubb, H. Chin, and D. L. Garbers. The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell 58: 1155-1162, 1989.
38. Siflinger-Birnboim, A., P. J. Del Vecchio, J. A. Cooper, F. A. Blumenstock, J. M. Shepard, and A. B. Malik. Molecular sieving characteristics of the cultured endothelial monolayer. J. Cell. Physiol. 132: 111-117, 1987.
39. Sill, H. W., Y. S. Chang, J. R. Artman, J. A. Frangos, and J. M. Tarbell. Shear stress increases hydraulic conductivity of cultured endothelial monolayers. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H535-H543, 1995.
40. Stelzner, T. J., J. V. Weil, and R. F. O'Brien. Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties. J. Cell. Physiol. 139: 157-166, 1989.
41. Takahashi, Z., P. D. Allen, and S. Izumo. Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles. Circ. Res. 71: 9-17, 1992.
42. Tucker, V. L. Contribution of ANP to plasma protein escape during VE: effects of thiorphan and atrial appendectomy. Am. J. Physiol. 271 (Regulatory Integrative Comp. Physiol. 40): R610-R618, 1996.
43. Tucker, V. L., K. E. Simanonok, and E. M. Renkin. Tissue-specific effects of physiological ANP infusion on blood-tissue albumin transport. Am. J. Physiol. 263 (Regulatory Integrative Comp. Physiol. 32): R945-R953, 1992.
44. Valentin, J. P., J. Ribstein, and A. Mimran. Effect of nicardipine and atriopeptin on transcapillary shift of fluid and proteins. Am. J. Physiol. 257 (Regulatory Integrative Comp. Physiol. 26): R174-R179, 1989.
45. 2-adenosine receptor stimulation increases macromolecule permeability of coronary endothelial cells. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H1174-H1181, 1992.
46. Westendorp, R. G. J., R. Draijer, A. E. Meinders, and V. W. M. van Hinsbergh. Cyclic-cGMP-mediated decrease in permeability of human umbilical and pulmonary artery endothelial cell monolayers. J. Vasc. Res. 31: 42-51, 1994.
47. Williamson, J. R., S. W. Holmberg, K. Chang, J. Marvel, S. P. Sutera, and P. Needleman. Mechanisms underlying atriopeptin-induced increases in hematocrit and vascular permeation in rats. Circ. Res. 64: 890-899, 1989.
48. Yonemaru, M., K. Ishii, F. Murad, and T. A. Raffin. Atriopeptin-induced increases in endothelial cell permeability are associated with elevated cGMP levels. Am. J. Physiol. 263 (Lung Cell. Mol. Physiol. 7): L363-L369, 1992.